Merit will take part inGEST 2022Oncology conference technology: global embolism.Features international audience this year's annual meeting, held in New York, New York seminar on-site training and practice.We is the theme of the conference this yearCurrents in the stand, provides a bold commitment, aims to improve doctors and their patients treatment effect of embolization therapy with high quality products and services.
Product exhibition booth no. 801
Embosphere ® microspheres
Most clinical studies spherical embolization agent, the MeritEmbosphere microspheresIs the clear choice for interventional radiologists.Designed for a predictable and enduring occlusion for symptomatic uterine fibroids embolization, ABM and vascular tumor, its elastic material to allow as much as 33% of temporary oppression, brought targeted results for patients and practitioners.
Gelatin Embocube ® embolism
Designed for vascular tumor embolism more and blood vessels are designed to block blood flow,Gelatin Embocube embolismAlways control the bleeding in the peripheral vasculature.Gelatin in pre-loaded 1 - mL or 3 - mL Medallion ® is evenly cut in the syringe, to help ensure seamless preparation and accurate delivery.
bob体育imSwiftNINJA ® micro catheter can be manipulated
SwiftNINJA micro catheter can be manipulatedStraight head tube is a kind of innovation, with panel in accordance with human body engineering, navigation Angle of 180 degrees, which can be controlled in the body.The device is composed of 80 centimeters far end hydrophilic coating, even in the most challenging vascular mouth can provide excellent accuracy and speed of navigation.
We are looking forward to seeing you in GEST 2022 -# rapids in the stand!
There is a problem, please contact usCustomer support centerAnd through live chat, phone or email conversation with one of our representative.
Before any Merit in using the above products, please refer to the instructions for indications, contraindications, warnings, cautions and instructions.
reference
- Laurent et al. 1996. "Trisacryl Gelatin Microspheres for Therapeutic Embolization, I: Development and In Vitro Evaluation." Am J Neuroradial returned from 3-540